• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对疑似特发性发作性睡病患者的32小时多导睡眠图进行活动监测。

Actigraphy against 32-hour polysomnography in patients with suspected idiopathic hypersomnia.

作者信息

Adam Tugdual, Tanty Jérôme, Barateau Lucie, Dauvilliers Yves

机构信息

Institute of Neurosciences of Montpellier (INM), University of Montpellier, INSERM, Montpellier, France.

Sleep-Wake Disorders Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, Montpellier, France.

出版信息

J Sleep Res. 2025 Feb 20:e70007. doi: 10.1111/jsr.70007.

DOI:10.1111/jsr.70007
PMID:39979124
Abstract

Actigraphy, a tool known for investigating sleep-wake patterns at home, lacks scientific validation in hypersomnolent subjects. We aim to validate an actigraphy-based sleep-wake prediction algorithm against 32-h continuous polysomnography in patients with suspected idiopathic hypersomnia, and to compare its performance to predict sleep-wake parameters assessed by polysomnography with those of a commercially available algorithm. Two hundred and six hypersomnolent subjects were included prospectively in a Reference Centre for Hypersomnias, and underwent a 32-h bedrest protocol, wearing wrist-actigraphy, to diagnose idiopathic hypersomnia. Among them, 126 patients (91 females, 30.6 ± 15.5 years, 101 idiopathic hypersomnia, 25 non-specified hypersomnia) with synchronised actigraphy and polysomnography were analysed. Age, sex, and Epworth Sleepiness Scale scores were collected. We trained various supervised algorithms and selected a recurrent neural network (S2S sequence-to-sequence long short-term memory network) for comparison with Actiwatch Software (AS) on sleep-wake variables and prediction errors during daytime and nighttime. S2S outperformed AS across all relevant metrics, and Bland-Altman analysis showed disagreement between the two algorithms. S2S had a lower absolute error than AS. AS mainly overestimated sleep, an overestimation that was substantially reduced with S2S, overall as well as during day and night. Performance was not correlated with age, sex, or subjective sleepiness, but objective sleepiness and longer sleep time on the bedrest were associated with sleep underestimation. Our S2S algorithm using deep learning performed better to predict sleep-wake parameters than AS and other commonly used algorithms. The next objective is to leverage this algorithm to study sleep-wake patterns in patients with hypersomnolence at home.

摘要

活动记录仪是一种用于在家中研究睡眠-觉醒模式的工具,但在患有过度嗜睡症的受试者中缺乏科学验证。我们旨在针对疑似特发性过度嗜睡症患者,通过32小时连续多导睡眠图来验证基于活动记录仪的睡眠-觉醒预测算法,并将其预测多导睡眠图评估的睡眠-觉醒参数的性能与一种商用算法的性能进行比较。206名过度嗜睡症受试者被前瞻性纳入一家过度嗜睡症参考中心,并接受了32小时卧床休息方案,期间佩戴腕部活动记录仪,以诊断特发性过度嗜睡症。其中,对126名活动记录仪和多导睡眠图同步的患者(91名女性,年龄30.6±15.5岁,101例特发性过度嗜睡症,25例未明确的过度嗜睡症)进行了分析。收集了年龄、性别和爱泼华嗜睡量表评分。我们训练了各种监督算法,并选择了一个递归神经网络(S2S序列到序列长短期记忆网络),以便在白天和夜间的睡眠-觉醒变量和预测误差方面与活动记录仪软件(AS)进行比较。在所有相关指标上,S2S的表现均优于AS,Bland-Altman分析显示这两种算法存在差异。S2S的绝对误差低于AS。AS主要高估了睡眠时间,而S2S在总体上以及白天和夜间都大幅减少了这种高估。性能与年龄、性别或主观嗜睡程度无关,但客观嗜睡程度和卧床休息时较长的睡眠时间与睡眠低估有关。我们使用深度学习的S2S算法在预测睡眠-觉醒参数方面比AS和其他常用算法表现更好。下一个目标是利用该算法在家中研究过度嗜睡症患者的睡眠-觉醒模式。

相似文献

1
Actigraphy against 32-hour polysomnography in patients with suspected idiopathic hypersomnia.针对疑似特发性发作性睡病患者的32小时多导睡眠图进行活动监测。
J Sleep Res. 2025 Feb 20:e70007. doi: 10.1111/jsr.70007.
2
Pharmacotherapies for sleep disturbances in dementia.痴呆症睡眠障碍的药物治疗
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
A Patient-centric Clinical Trial Design to Comprehensively Evaluate Low-Sodium Oxybate in People with Idiopathic Hypersomnia or Narcolepsy.一项以患者为中心的临床试验设计,旨在全面评估低钠羟丁酸钠在发作性睡病或特发性过度睡眠患者中的疗效。
Neurol Ther. 2025 Jun 9. doi: 10.1007/s40120-025-00745-7.
5
Pharmacotherapies for sleep disturbances in Alzheimer's disease.用于治疗阿尔茨海默病睡眠障碍的药物疗法。
Cochrane Database Syst Rev. 2014 Mar 21(3):CD009178. doi: 10.1002/14651858.CD009178.pub2.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
Non-pharmacological interventions for sleep promotion in hospitalized children.促进住院儿童睡眠的非药物干预措施。
Cochrane Database Syst Rev. 2022 Jun 15;6(6):CD012908. doi: 10.1002/14651858.CD012908.pub2.
8
Melatonin for the promotion of sleep in adults in the intensive care unit.褪黑素用于促进重症监护病房成年患者的睡眠。
Cochrane Database Syst Rev. 2018 May 10;5(5):CD012455. doi: 10.1002/14651858.CD012455.pub2.
9
Tonsillectomy or adenotonsillectomy versus non-surgical management for obstructive sleep-disordered breathing in children.扁桃体切除术或腺样体扁桃体切除术与非手术治疗对儿童阻塞性睡眠呼吸障碍的疗效比较
Cochrane Database Syst Rev. 2015 Oct 14;2015(10):CD011165. doi: 10.1002/14651858.CD011165.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.